Search Results - "Nomoto, M."
-
1
Curcumin ameliorates streptozotocin-induced liver damage through modulation of endoplasmic reticulum stress-mediated apoptosis in diabetic rats
Published in Free radical research (01-03-2015)“…We investigated the effect of curcumin on liver injury in diabetic rats induced by streptozotocin (STZ) through modulation of endoplasmic reticulum stress…”
Get more information
Journal Article -
2
Regular Immunological Evaluations for Progression of Cardiac Allograft Vasculopathy
Published in The Journal of heart and lung transplantation (01-04-2020)“…The methods for detection of post-transplant rejection, especially antibody-mediated rejection (AMR) have been developed for the past three decades and…”
Get full text
Journal Article -
3
Promoter CpG methylation in cancer cells contributes to the regulation of MUC4
Published in British journal of cancer (27-01-2009)“…Mucin 4 (MUC4) is a high molecular weight transmembrane mucin that is overexpressed in many carcinomas and is a risk factor associated with a poor prognosis…”
Get full text
Journal Article -
4
P0327 : Analysis of hepatic progenitor cell marker positive hepatocellular carcinoma and their prognostic significance
Published in Journal of hepatology (01-04-2015)Get full text
Journal Article -
5
Study to evaluate the safety, dosage levels and response to inosine administration in Parkinson's disease
Published in Journal of the neurological sciences (15-10-2015)Get full text
Journal Article -
6
Zonisamide up-regulated the mRNAs encoding astrocytic anti-oxidative and neurotrophic factors
Published in European journal of pharmacology (15-08-2012)“…Zonisamide has been proven as an effective drug for the recovery of degenerating dopaminergic neurons in the animal models of Parkinson's disease. However,…”
Get full text
Journal Article -
7
Plasma amantadine concentrations in patients with Parkinson's disease
Published in Parkinsonism & related disorders (01-06-2009)“…Abstract We determined plasma amantadine concentrations in patients with Parkinson's disease (PD) in daily clinical practice and investigated the relationship…”
Get full text
Journal Article -
8
PP033—Effects of pregabalin on driving
Published in Clinical therapeutics (01-08-2013)Get full text
Journal Article -
9
Randomized placebo‐controlled trial of zonisamide in patients with Parkinson's disease
Published in Neurology and clinical neuroscience (01-01-2016)“…Background We previously showed that zonisamide significantly improved parkinsonian symptoms by a multicenter, double‐blind clinical trial. Aim To confirm the…”
Get full text
Journal Article -
10
Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma
Published in Histopathology (01-01-2003)“…Aims: Mucinous carcinoma of the breast usually shows less frequent lymph node metastasis and more favourable outcome compared with invasive ductal carcinoma…”
Get full text
Journal Article -
11
-
12
Delayed l-DOPA-induced hyperalgesia
Published in Pharmacology, biochemistry and behavior (01-11-2006)“…Previously we reported on l-DOPA's antinociceptive effect on substance P-induced nociceptive behaviors in mice [Shimizu T, Iwata S, Morioka H, Masuyama T,…”
Get full text
Journal Article -
13
P5-12 Evaluation of patients with Parkinson's disease using driving simulator in comparison with neurological signs
Published in Clinical neurophysiology (2010)Get full text
Journal Article -
14
Structural Effects of O-Glycosylation on a 15-Residue Peptide from the Mucin (MUC1) Core Protein
Published in Biochemistry (Easton) (03-10-2000)“…To study the effect of O-glycosylation on the conformational propensities of a peptide backbone, the 15-residue peptide PPAHGVTSAPDTRPA (PPA15) from the MUC1…”
Get full text
Journal Article -
15
Effect of grapefruit juice on cabergoline pharmacokinetics in patients with Parkinson's disease
Published in Clinical pharmacology and therapeutics (01-02-2005)“…Background Cabergoline is one of the synthetic ergoline dopamine agonists, which is widely used for the treatment of Parkinson's disease (PD). Cytochrome P‐450…”
Get full text
Journal Article -
16
A CYP3A4 inhibitor increased the effect of cabergoline in the treatment of Parkinson's disease
Published in Clinical pharmacology and therapeutics (01-02-2005)“…Introduction Cabergoline is a synthetic ergote dopamine agonist that is metabolized by CYP3A4, is applied in the treatment of Parkinson's disease (PD)…”
Get full text
Journal Article -
17
Pharmacokinetic study on the interaction between cabergoline and clarithromycin in healthy volunteers and patients with parkinson's disease
Published in Clinical pharmacology and therapeutics (01-02-2004)“…Pharmacokinetic interaction between cabergoline, a dopamine receptor agonist and a macrolide, clarithromycin was studied in healthy volunteers and patients…”
Get full text
Journal Article -
18
1.323 Siblings of SCA type 2 with heterogenous neurodegenerative disorders
Published in Parkinsonism & related disorders (2007)Get full text
Journal Article -
19
Morphological and functional characterization of hemocytes in the giant clam Tridacna crocea
Published in Journal of invertebrate pathology (01-03-1997)“…In order to understand the cellular defense system in the giant clam Tridacna crocea, which harbors symbiotic microalga zooxanthella, hemocytes of the giant…”
Get full text
Journal Article -
20
Circulating immunoglobulin‐bound transforming growth factor β at a late tumour‐bearing stage impairs antigen‐specific responses of CD4+ T cells
Published in Clinical and experimental immunology (01-05-2002)“…SUMMARY In order to elucidate the mechanisms by which tumour‐specific CD4+ T‐cell responses are impaired during tumour development, an attempt was made to…”
Get full text
Journal Article